Related Experiment Video
Updated: May 11, 2026

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
Survival factor NFIL3 restricts FOXO-induced gene expression in cancer
Megan Keniry1, Maira M Pires, Sarah Mense
1Institute for Cancer Genetics, Columbia University, New York, New York 10032, USA.
Abstract:
Depending on the circumstance, FOXO (Forkhead O) (FOXO1, FOXO3, and FOXO4) transcription factors activate the expression of markedly different sets of genes to produce different phenotypic effects. For example, distinct FOXO-regulated transcriptional programs stimulate cell death or enhance organism life span. To gain insight into how FOXOs select specific genes for regulation, we performed a screen for genes that modify FOXO activation of TRAIL, a death receptor ligand capable of inducing extrinsic apoptosis. We discovered that the bZIP transcriptional repressor NFIL3 (nuclear factor interleukin 3-regulated) hindered FOXO transcription factor access to chromatin at the TRAIL promoter by binding to nearby DNA and recruiting histone deacetylase-2 (HDAC2) to reduce histone acetylation. In the same manner, NFIL3 repressed expression of certain FOXO targets--e.g., FAS, GADD45α (growth arrest and DNA damage-inducible, α), and GADD45β--but not others. NFIL3, which we found to be overexpressed in different cancers, supported tumor cell survival largely through repression of TRAIL and antagonized hydrogen peroxide-induced cell death. Moreover, its expression in cancer was associated with lower patient survival. Therefore, NFIL3 alters cancer cell behavior and FOXO function by acting on chromatin to restrict the menu of FOXO target genes. Targeting of NFIL3 could be of therapeutic benefit for cancer patients.
Insights
Nuclear factor interleukin 3-regulated (NFIL3) represses FOXO transcription factors, impacting cancer cell survival and death. Targeting NFIL3 may offer therapeutic benefits for cancer patients by restoring FOXO-regulated gene expression.
Area of Science:
- Molecular Biology
- Cancer Biology
- Epigenetics
Background:
- FOXO transcription factors regulate diverse cellular processes, including cell death and lifespan.
- Understanding how FOXO factors select specific target genes is crucial for deciphering their varied functions.
Purpose of the Study:
- To identify genes that modulate FOXO transcription factor activity, specifically focusing on the regulation of TRAIL (TNF-related apoptosis-inducing ligand).
- To investigate the role of NFIL3 in FOXO-mediated gene regulation and its implications in cancer.
Main Methods:
- A genetic screen was employed to identify modifiers of FOXO activation of the TRAIL promoter.
- Chromatin immunoprecipitation and reporter assays were used to assess NFIL3 binding and its effect on histone acetylation.
- Expression analysis of NFIL3 in various cancer types and correlation with patient survival.
Main Results:
- NFIL3, a bZIP transcriptional repressor, was identified as an inhibitor of FOXO transcription factor access to the TRAIL promoter.
- NFIL3 recruits histone deacetylase-2 (HDAC2), leading to reduced histone acetylation and repression of FOXO target genes like FAS and GADD45.
- NFIL3 overexpression in cancers correlates with reduced patient survival and promotes tumor cell survival by repressing TRAIL and antagonizing cell death.
Conclusions:
- NFIL3 functions as a critical regulator of FOXO-mediated gene expression by altering chromatin accessibility.
- NFIL3's repression of specific FOXO targets, including TRAIL, contributes to cancer cell survival and poor prognosis.
- Targeting NFIL3 presents a potential therapeutic strategy for enhancing cancer treatment efficacy.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Regulation of Angiogenesis and Blood Supply
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
